Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Moran Sean F.
Relationship:   Chief Financial Officer
City:   Columbia
State:   MD
   
Insider Summary:
  
   
Companies Owned :   3    
Direct Shares   143,605    

Indirect Shares

   0      
Direct Value   $2,269,764    

Indirect Value

   $0      
Total Shares   143,605      
Total Value   $2,269,764      


Celsion Corp $49,700 Invivo Therapeutics Holdings Corporation $23,118 Corbus Pharmaceuticals Holdings, Inc. $2,196,946 Celsion Corp $49,700 Invivo Therapeutics Holdings Corporation $23,118 Corbus Pharmaceuticals Holdings, Inc. $2,196,946
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    3   
    0    

     Stock price went up :
    1   
    0    
     Stock price went down :
    2   
    0    
   
     Gain/Loss Ratio :
   0.0   
   0.0   
     Percentage Gain/Loss :
   1,046.1%
   0.0%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Celsion Corp CLSN Chief Financial Officer 2009-03-17 35,000 2009-01-19 0    Premium*  
            Invivo Therapeutics Holdings Cor... NVIV Acting Chief Financial... 2013-09-03 60,000 2013-08-29 0    Premium*  
            Corbus Pharmaceuticals Holdings,... CRBP Chief Financial Officer 2024-04-10 48,605 2014-11-25 0    Premium*  
* Premium Members only  

Records found :    61         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 1 of 3
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
CRBP Corbus Pharmaceuticals Ho... Chief Financial Officer   •       –      –    2024-02-12 4 A $0.00 $0 D/D 40,176 46,818 0 -
CRBP Corbus Pharmaceuticals Ho... Chief Financial Officer   •       –      –    2020-12-16 4 OE $0.17 $6,118 D/D 36,923 386,533 0 -
CRBP Corbus Pharmaceuticals Ho... Chief Financial Officer   •       –      –    2022-08-10 4 B $0.26 $5,198 D/D 20,000 199,272 2.74 %
CRBP Corbus Pharmaceuticals Ho... Chief Financial Officer   •       –      –    2022-05-16 4 B $0.30 $3,600 D/D 12,000 179,272 2.66 %
CRBP Corbus Pharmaceuticals Ho... Chief Financial Officer   •       –      –    2022-03-10 4 B $0.37 $5,550 D/D 15,000 167,272 2.74 %
CRBP Corbus Pharmaceuticals Ho... Chief Financial Officer   •       –      –    2020-12-18 4 OE $1.00 $53,610 D/D 53,610 403,220 0 -
NVIV Invivo Therapeutics Holdi... Acting Chief Financial Officer   •       –      –    2013-09-03 4 B $1.02 $20,400 D/D 20,000 60,000 2.74 -
NVIV Invivo Therapeutics Holdi... Acting Chief Financial Officer   •       –      –    2013-08-29 4 S $1.23 $34,440 D/D (28,000) 28,000 0 -
NVIV Invivo Therapeutics Holdi... Acting Chief Financial Officer   •       –      –    2013-08-29 4/A B $1.23 $34,440 D/D 28,000 28,000 2.74 -
CRBP Corbus Pharmaceuticals Ho... Chief Financial Officer   •       –      –    2020-12-16 4 AS $1.32 $48,628 D/D (36,923) 349,610 0 %
CRBP Corbus Pharmaceuticals Ho... Chief Financial Officer   •       –      –    2020-12-18 4 AS $1.40 $75,054 D/D (53,610) 349,610 0 %
CRBP Corbus Pharmaceuticals Ho... Chief Financial Officer   •       –      –    2020-12-21 4 OE $1.40 $122,500 D/D 87,500 437,110 0 -
NVIV Invivo Therapeutics Holdi... Acting Chief Financial Officer   •       –      –    2013-08-30 4/A B $1.47 $17,640 D/D 12,000 40,000 2.74 -
NVIV Invivo Therapeutics Holdi... Acting Chief Financial Officer   •       –      –    2013-08-30 4 S $1.47 $17,640 D/D (12,000) 40,000 0 -
CRBP Corbus Pharmaceuticals Ho... Chief Financial Officer   •       –      –    2015-12-11 4 B $1.56 $1,559 D/D 1,000 75,250 2.66 -
CRBP Corbus Pharmaceuticals Ho... Chief Financial Officer   •       –      –    2015-12-10 4 B $1.61 $1,611 D/D 1,000 74,250 2.66 -
CRBP Corbus Pharmaceuticals Ho... Chief Financial Officer   •       –      –    2015-12-09 4 B $1.67 $1,670 D/D 1,000 73,250 2.66 -
CRBP Corbus Pharmaceuticals Ho... Chief Financial Officer   •       –      –    2015-12-08 4 B $1.68 $1,682 D/D 1,000 72,250 2.66 -
CRBP Corbus Pharmaceuticals Ho... Chief Financial Officer   •       –      –    2015-11-16 4 B $1.69 $3,372 D/D 2,000 62,250 2.66 -
CRBP Corbus Pharmaceuticals Ho... Chief Financial Officer   •       –      –    2015-12-07 4 B $1.69 $1,689 D/D 1,000 71,250 2.66 -
CRBP Corbus Pharmaceuticals Ho... Chief Financial Officer   •       –      –    2015-11-20 4 B $1.70 $2,548 D/D 1,500 66,750 2.66 -
CRBP Corbus Pharmaceuticals Ho... Chief Financial Officer   •       –      –    2015-11-18 4 B $1.71 $2,565 D/D 1,500 65,250 2.66 -
CRBP Corbus Pharmaceuticals Ho... Chief Financial Officer   •       –      –    2015-11-17 4 B $1.72 $2,583 D/D 1,500 63,750 2.66 -
CRBP Corbus Pharmaceuticals Ho... Chief Financial Officer   •       –      –    2015-12-04 4 B $1.72 $1,720 D/D 1,000 70,250 2.66 -
CRBP Corbus Pharmaceuticals Ho... Chief Financial Officer   •       –      –    2020-12-21 4 AS $1.75 $153,125 D/D (87,500) 349,610 0 %
  61  Records found
  1  2   3      
  Page 1 of 3  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us